These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14598319)

  • 1. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators are involved in the degradation of bone by osteoclasts.
    Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
    Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci; 2001 Jun; 21(12):4336-47. PubMed ID: 11404419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes to plasminogen activators and matrix metalloproteinase-9 in dogs with toxocarosis.
    Lai SC; Chen KM
    Vet Parasitol; 2007 Nov; 150(1-2):122-7. PubMed ID: 17913363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of tissue plasminogen activator gene reduces macrophage migration.
    Ling C; Zou T; Hsiao Y; Tao X; Chen ZL; Strickland S; Song H
    Biochem Biophys Res Commun; 2006 Oct; 349(3):906-12. PubMed ID: 16978586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
    Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix and matrix metalloproteinases in sciatic nerve.
    Platt CI; Krekoski CA; Ward RV; Edwards DR; Gavrilovic J
    J Neurosci Res; 2003 Nov; 74(3):417-29. PubMed ID: 14598318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci; 2001 Jun; 21(12):4348-55. PubMed ID: 11404420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
    Maupas-Schwalm F; Bedel A; Augé N; Grazide MH; Mucher E; Thiers JC; Salvayre R; Nègre-Salvayre A
    Cell Signal; 2009 Dec; 21(12):1925-34. PubMed ID: 19735728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
    Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator expression correlates with genetic differences in vascular remodeling.
    Korshunov VA; Solomatina MA; Plekhanova OS; Parfyonova YV; Tkachuk VA; Berk BC
    J Vasc Res; 2004; 41(6):481-90. PubMed ID: 15528930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
    Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W
    Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.